MacroGenics (MGNX) Stock: Buy, Sell, or Hold?
$2.32
-0.10 (-4.13%)
▼
5d:
+0.43%
30d:
-32.16%
90d:
-43.14%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (92%)
Quality Score
69/100
Position
OVERSOLD
30-Day Fair Range
$2.32 – $3.54
Position: OVERSOLD
Forward P/E & Valuation
-1.6x
Next 12M consensus est.
Wall Street Target
$8.00
+244.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.21 / $2.59
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: MGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When MGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MGNX is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.32 to $3.54.
Technical Outlook: Technically, MGNX is in a strong downtrend. Immediate support is located at $2.21, while resistance sits at $2.59. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: MGNX scores 90/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.00 (+244.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MGNX is in a strong downtrend. Immediate support is located at $2.21, while resistance sits at $2.59. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: MGNX scores 90/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.00 (+244.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.32 -
$3.54
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
91.7%
Trading Range & Key Levels
30-Day Trading Range
$2.32 -
$3.54
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.22
(9.3%)
Support Level
$2.21
Resistance Level
$2.59
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (90/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 244.8% below Wall St target ($8.00)
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-1.58
Wall Street Target
$8.00
(+244.8%)
Revenue Growth (YoY)
378.0%
Earnings Growth (YoY)
-70.4%
Profit Margin
-8.3%
Share MGNX Analysis
Share this live MGNX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MGNX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 26, 2026
Daily AI digest
AI Retail Discussion Summary:
MacroGenics reported positive interim Phase 2 results for lorigerlimab in advanced clear cell gynecologic cancer with a confirmed ORR of 25% and a DCR of 44%.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MGNX Research Pages
